Doctor profile · Federal record
Dr. Tazeen Rehman, M.D.
Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · Baltimore, MD
- NPI 1427241132
- Accepts Medicare
- MIPS 80.7 / 100 · 2023
- 24 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1220B E Joppa RD, Suite 310
Baltimore, MD 212865813
(410) 494-1888
fax (410) 494-1008
Credentials & registration
- NPI registered
- August 2007 — 19 yrs on file
- Profile last updated
- September 4, 2020
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- Maryland #D0068650 · Maryland #P21915
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1427241132. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
115,969
Distinct HCPCS
10
Medicare allowed
$2,022,370
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 72,400 | 25 | $5 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 21,202 | 35 | $42 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 7,915 | 11 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 4,401 | 12 | $33 | |
J9312 |
Injection, rituximab, 10 mg | 2,901 | 12 | $80 | |
J0897 |
Injection, denosumab, 1 mg | 2,581 | 26 | $23 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 705 | 364 | $96 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 510 | 77 | $144 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 421 | 66 | $77 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 390 | 48 | $1 |
In context: peer comparison
Among 15 peers in Baltimore Rheumatology Physician, average services per provider: 1,601. This provider delivers 72× the peer median.Open Payments
Industry payments received
All-time total
$298
Transactions
19
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 13 | $157.00 | |
| Novartis Pharmaceuticals Corporation | 2 | $50.40 | |
| Aurinia Pharma U.S., INC. | 1 | $29.65 | |
| Amgen INC. | 1 | $23.01 | |
| Pfizer INC. | 1 | $21.26 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $17.02 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,560
Patients
438
Total drug cost
$416,449
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 341 | 98 | $16,664 |
| Prednisone | Generic | 267 | 84 | $2,858 |
| Hydroxychloroquine Sulfate | Generic | 232 | 74 | $16,892 |
| Leflunomide | Generic | 136 | 45 | $12,702 |
| Gabapentin | Generic | 91 | 31 | $2,088 |
| Duloxetine Hcl | Generic | 81 | 29 | $3,095 |
| Tramadol Hcl | Generic | 66 | 21 | $455 |
| Oxycodone Hcl | Generic | 57 | 0 | $1,407 |
| Leucovorin Calcium | Generic | 54 | 19 | $1,892 |
| Alendronate Sodium | Generic | 51 | 15 | $608 |
Hospital affiliations
Frequently asked questions
What is Dr. Tazeen Rehman's medical specialty?
Dr. Tazeen Rehman practices Rheumatology Physician in Baltimore, MD.
Where does Dr. Tazeen Rehman practice?
Dr. Tazeen Rehman practices at 1220B E Joppa RD, Baltimore, MD 212865813. Office phone: 4104941888.
What is Dr. Tazeen Rehman's NPI?
Dr. Tazeen Rehman's National Provider Identifier (NPI) is 1427241132, issued by NPPES.
Does Dr. Tazeen Rehman accept Medicare assignment?
Yes. Dr. Tazeen Rehman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tazeen Rehman commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.